1. Targeting c-Met in the treatment of urologic neoplasms: Current status and challenges
   Pengxiao Su et al, 2023, Frontiers in Oncology CrossRef
2. Macrophage Gal/GalNAc lectin 2 (MGL2)+ peritoneal antigen presenting cells during Fasciola hepatica infection are essential for regulatory T cell induction
   Monique Costa et al, 2022, Scientific Reports CrossRef
3. c-Met: A Promising Therapeutic Target in Bladder Cancer
   Yanfei Feng et al, 2022, Cancer Management and Research CrossRef